Gavrilov Ognian Anguelov - 20 Aug 2025 SCHEDULE 13G Report for Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value (CLDI)

Filing Manager: Gavrilov Ognian Anguelov
Reporting Manager: Gavrilov Ognian Anguelov
Security: Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value
Symbol: CLDI
Shares outstanding: 7,179,487 shares
Disclosed Ownership: 560,000 shares
Ownership: 7.8%
Form type: SCHEDULE 13G
Filing time: 04 Feb 2026, 15:06:22 UTC
Date of event: 20 Aug 2025
Next filing: 09 Mar 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Gavrilov Ognian Anguelov	7.8%	560,000	560,000	0	Ognian Anguelov Gavrilov	Managing Partner